Sandra Horning - 06 May 2024 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
06 May 2024
Net transactions value
$0
Form type
4
Filing time
07 May 2024, 16:54:53 UTC
Previous filing
14 Nov 2023
Next filing
09 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +5,668 $0.000000 5,668 06 May 2024 Common Stock 5,668 $122.13 Direct F1
transaction MRNA Restricted Stock Units Award $0 +979 $0.000000 979 06 May 2024 Common Stock 979 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.